Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair

Publication date: Available online 16 October 2019Source: Pharmacology & TherapeuticsAuthor(s): Suya Wang, Jianshi Yu, Maureen A. Kane, Alexander R. MoiseAbstractThe vitamin A metabolite, retinoic acid, is an important signaling molecule during embryonic development serving critical roles in morphogenesis, organ patterning and skeletal and neural development. Retinoic acid is also important in postnatal life in the maintenance of tissue homeostasis, while retinoid-based therapies have long been used in the treatment of a variety of cancers and skin disorders. As the number of people living with chronic disorders continues to increase, there is great interest in extending the use of retinoid therapies in promoting the maintenance and repair of adult tissues. However, there are still many conflicting results as we struggle to understand the role of retinoic acid in the multitude of processes that contribute to tissue injury and repair. This review will assess our current knowledge of the role retinoic acid signaling in the development of fibroblasts, and their transformation to myofibroblasts, and of the potential use of retinoid therapies in the treatment of organ fibrosis.
Source: Pharmacology and Therapeutics - Category: Drugs & Pharmacology Source Type: research